Director Lindsay Androski resigns from Eloxx board effective August 6, 2025

Eloxx Pharmaceuticals, Inc.

Lindsay Androski notified the Board of her resignation, effective immediately on August 6, 2025.
Resignation was not due to any disagreement with the Company's operations, policies, or practices.
No replacement director has been announced; board size reduced accordingly.

item 5.02 item 9.01

Eloxx Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-076933

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.